People with MS often feel anxious about MRIs and frequently lack basic knowledge of this diagnostic procedure. Is an education program that creates “expert patients” the answer?

Following on the heels of a confirmed case of the rare brain infection progressive multifocal leukoencephalopathy in an MS patient taking dimethyl fumarate, the FDA has just released a warning about the potential for infections in more people

Reversing a decision made in 2013, the FDA approved Lemtrada (Genzyme/Sanofi) in a restricted program for relapsing forms of MS

One Clinic’s Tecfidera PML Guidelines; Innovation Award for MS Genomics; Journalism Prize to MSDF Contributor